IL273528B2 - Long-acting conjugates of glp-2 derivatives - Google Patents
Long-acting conjugates of glp-2 derivativesInfo
- Publication number
- IL273528B2 IL273528B2 IL273528A IL27352820A IL273528B2 IL 273528 B2 IL273528 B2 IL 273528B2 IL 273528 A IL273528 A IL 273528A IL 27352820 A IL27352820 A IL 27352820A IL 273528 B2 IL273528 B2 IL 273528B2
- Authority
- IL
- Israel
- Prior art keywords
- glp
- derivative
- lysine
- group
- region
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/605—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/52—Constant or Fc region; Isotype
- C07K2317/53—Hinge
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20170126577 | 2017-09-28 | ||
| PCT/KR2018/011586 WO2019066586A1 (ko) | 2017-09-28 | 2018-09-28 | 글루카곤 유사 펩타이드-2(glp-2) 유도체의 지속형 결합체 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| IL273528A IL273528A (en) | 2020-05-31 |
| IL273528B1 IL273528B1 (en) | 2025-04-01 |
| IL273528B2 true IL273528B2 (en) | 2025-08-01 |
Family
ID=65902619
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL273528A IL273528B2 (en) | 2017-09-28 | 2018-09-28 | Long-acting conjugates of glp-2 derivatives |
Country Status (22)
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11202111312UA (en) | 2019-06-14 | 2021-12-30 | Zealand Pharma As | Pharmaceutical parenteral composition of dual glp1/2 agonist |
| EP4082561A4 (en) * | 2019-12-24 | 2024-02-07 | Hanmi Pharm. Co., Ltd. | Pharmaceutical composition for preventing or treating metabolic bone diseases, comprising glp-2 or conjugate thereof |
| US20230110689A1 (en) | 2020-03-30 | 2023-04-13 | Zealand Pharma A/S | Agonist combination |
| CN115697375A (zh) * | 2020-04-03 | 2023-02-03 | 韩美药品株式会社 | 预防或治疗放疗、化疗或其组合引发的粘膜炎的包含glp-2衍生物或其长效缀合物的药物组合物 |
| IL298298A (en) | 2020-05-22 | 2023-01-01 | Hanmi Pharm Ind Co Ltd | A liquid formulation of a long-acting conjugate of glp–2 |
| CA3182260A1 (en) | 2020-06-09 | 2021-12-16 | Gleb Feldman | Manufacture, formulation and dosing of apraglutide |
| CA3201916A1 (en) * | 2020-12-24 | 2022-06-30 | Hanmi Pharm. Co., Ltd. | Combination therapy of insulinotropic peptide and glp-2, for preventing or treating short bowel syndrome |
| US20250276044A1 (en) * | 2022-04-18 | 2025-09-04 | Hanmi Pharm. Co., Ltd. | COMBINATION THERAPY COMPRISING GLP-2, AND INSULINOTROPIC PEPTIDE, TNFa INHIBITOR, OR BOTH FOR PREVENTING OR TREATING BOWEL DISEASE |
| JP2026501948A (ja) | 2022-12-23 | 2026-01-19 | ハンミ ファーマシューティカル カンパニー リミテッド | Glp-2誘導体又はその持続型結合体を含む移植片対宿主病の予防又は治療用薬学的組成物 |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005103087A1 (en) * | 2004-04-23 | 2005-11-03 | Conjuchem Biotechnologies Inc. | Method for the purification of albumin conjugates |
| WO2010042145A1 (en) * | 2008-09-19 | 2010-04-15 | Nektar Therapeutics | Polymer conjugates of glp-2-like peptides |
| KR20110093924A (ko) * | 2005-05-04 | 2011-08-18 | 질랜드 파마 에이/에스 | 글루카곤 유사 펩티드-2(glp-2) 유사체 |
| KR20120043205A (ko) * | 2010-10-26 | 2012-05-04 | 한미사이언스 주식회사 | 면역글로불린 단편을 이용한 글루카곤 유사 펩타이드?2(glp?2)약물 결합체 |
| KR20130078634A (ko) * | 2011-12-30 | 2013-07-10 | 한미사이언스 주식회사 | 면역글로불린 단편을 이용한 위치 특이적 글루카곤 유사 펩타이드-2 약물 결합체 |
| KR20140069131A (ko) * | 2011-09-12 | 2014-06-09 | 아뮤닉스 오퍼레이팅 인코포레이티드 | 글루카곤-유사 펩티드-2 조성물 및 이의 제조 및 사용 방법 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6096871A (en) | 1995-04-14 | 2000-08-01 | Genentech, Inc. | Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life |
| CA2249195A1 (en) | 1996-03-18 | 1997-09-25 | Board Of Regents, The University Of Texas System | Immunoglobin-like domains with increased half lives |
| DK1360202T3 (da) * | 2001-02-16 | 2008-09-22 | Conjuchem Biotechnologies Inc | Langvarigt glucagon-lignende peptid 2 (GLP-2) til behandling af gastrointestinale sygdomme og lidelser |
| US20090238838A1 (en) * | 2003-11-13 | 2009-09-24 | Hanmi Pharm. Ind. Co. Ltd. | Insulinotropic peptide conjugate using an immunoglobulin fc |
| JP2008169195A (ja) * | 2007-01-05 | 2008-07-24 | Hanmi Pharmaceutical Co Ltd | キャリア物質を用いたインスリン分泌ペプチド薬物結合体 |
-
2018
- 2018-09-28 AR ARP180102806A patent/AR113258A1/es unknown
- 2018-09-28 AU AU2018339210A patent/AU2018339210B2/en active Active
- 2018-09-28 MX MX2020004453A patent/MX2020004453A/es unknown
- 2018-09-28 KR KR1020180116327A patent/KR102681143B1/ko active Active
- 2018-09-28 BR BR112020006189-1A patent/BR112020006189A2/pt unknown
- 2018-09-28 IL IL273528A patent/IL273528B2/en unknown
- 2018-09-28 TW TW110126453A patent/TWI794897B/zh active
- 2018-09-28 FI FIEP18860379.9T patent/FI3689898T3/fi active
- 2018-09-28 ES ES18860379T patent/ES3075688T3/es active Active
- 2018-09-28 JP JP2020517828A patent/JP7751381B2/ja active Active
- 2018-09-28 EA EA202090571A patent/EA202090571A1/ru unknown
- 2018-09-28 WO PCT/KR2018/011586 patent/WO2019066586A1/ko not_active Ceased
- 2018-09-28 CA CA3084326A patent/CA3084326A1/en active Pending
- 2018-09-28 DK DK18860379.9T patent/DK3689898T3/da active
- 2018-09-28 CN CN201880074180.4A patent/CN111433221B/zh active Active
- 2018-09-28 SG SG11202002563WA patent/SG11202002563WA/en unknown
- 2018-09-28 PT PT188603799T patent/PT3689898T/pt unknown
- 2018-09-28 TW TW107134398A patent/TWI795443B/zh active
- 2018-09-28 EP EP18860379.9A patent/EP3689898B1/en active Active
-
2020
- 2020-03-19 PH PH12020550105A patent/PH12020550105A1/en unknown
- 2020-03-24 ZA ZA2020/01888A patent/ZA202001888B/en unknown
- 2020-03-27 US US16/832,634 patent/US11530249B2/en active Active
- 2020-03-28 SA SA520411644A patent/SA520411644B1/ar unknown
-
2022
- 2022-04-14 US US17/721,048 patent/US12703730B2/en active Active
- 2022-11-02 US US17/979,531 patent/US20230090790A1/en not_active Abandoned
-
2023
- 2023-07-06 JP JP2023111438A patent/JP2023138505A/ja active Pending
-
2024
- 2024-01-22 KR KR1020240009740A patent/KR102681144B1/ko active Active
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005103087A1 (en) * | 2004-04-23 | 2005-11-03 | Conjuchem Biotechnologies Inc. | Method for the purification of albumin conjugates |
| KR20110093924A (ko) * | 2005-05-04 | 2011-08-18 | 질랜드 파마 에이/에스 | 글루카곤 유사 펩티드-2(glp-2) 유사체 |
| WO2010042145A1 (en) * | 2008-09-19 | 2010-04-15 | Nektar Therapeutics | Polymer conjugates of glp-2-like peptides |
| KR20120043205A (ko) * | 2010-10-26 | 2012-05-04 | 한미사이언스 주식회사 | 면역글로불린 단편을 이용한 글루카곤 유사 펩타이드?2(glp?2)약물 결합체 |
| KR20140069131A (ko) * | 2011-09-12 | 2014-06-09 | 아뮤닉스 오퍼레이팅 인코포레이티드 | 글루카곤-유사 펩티드-2 조성물 및 이의 제조 및 사용 방법 |
| KR20130078634A (ko) * | 2011-12-30 | 2013-07-10 | 한미사이언스 주식회사 | 면역글로불린 단편을 이용한 위치 특이적 글루카곤 유사 펩타이드-2 약물 결합체 |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL273528B1 (en) | Long-acting conjugates of GLP-2 derivatives | |
| JP2020534840A5 (cg-RX-API-DMAC7.html) | ||
| Fathi et al. | Elastin based cell-laden injectable hydrogels with tunable gelation, mechanical and biodegradation properties | |
| AU2020210919B2 (en) | Glycoside-containing peptide linkers for antibody-drug conjugates | |
| Luo et al. | Biodegradable multiblock poly [N-(2-hydroxypropyl) methacrylamide] via reversible addition− fragmentation chain transfer polymerization and click chemistry | |
| Geng et al. | Site-directed conjugation of “clicked” glycopolymers to form glycoprotein mimics: binding to mammalian lectin and induction of immunological function | |
| KR101770844B1 (ko) | 폴리에틸렌 글리콜 기반의 생분해성 수불용성 하이드로겔 | |
| You et al. | Synthesis of temperature-responsive heterobifunctional block copolymers of poly (ethylene glycol) and poly (N-isopropylacrylamide) | |
| AU650900B2 (en) | New linker for bioactive agents | |
| JP4824404B2 (ja) | 脂肪族生物分解性リンカーに基づく放出可能なポリマー複合体 | |
| RU2009129953A (ru) | Инсулинотропный комплекс, в котором использован фрагмент иммуноглобулина | |
| NZ630888A (en) | Antibody drug conjugate (adc) purification | |
| JP2015503554A5 (cg-RX-API-DMAC7.html) | ||
| JP2010503706A (ja) | リジン系ポリマーリンカー | |
| GB2529356A (en) | Novel linker and preparation method thereof | |
| CA2558583C (en) | Polymer-based compositions and conjugates of hiv entry inhibitors | |
| KR20170071485A (ko) | Peg의 일부를 포함하는 이탈기를 포함하는 시약을 사용한, 펩티드 또는 단백질의 접합방법 | |
| Reyes-Ortega et al. | Smart heparin-based bioconjugates synthesized by a combination of ATRP and click chemistry | |
| Williams et al. | RAFT‐Derived Polymer–Drug Conjugates: Poly (hydroxypropyl methacrylamide)(HPMA)–7‐Ethyl‐10‐hydroxycamptothecin (SN‐38) Conjugates | |
| Hakimi et al. | Thiolated methylated dimethylaminobenzyl chitosan: A novel chitosan derivative as a potential delivery vehicle | |
| US20050276858A1 (en) | Bifunctional-modified hydrogels | |
| Collins et al. | Stability enhancing N-terminal PEgylation of oxytocin exploiting different polymer architectures and conjugation approaches | |
| WO2023201335A3 (en) | Purified multivalent protein-hyaluronic acid polymer conjugates | |
| Joshi et al. | Synthesis of potent inhibitors of anthrax toxin based on poly-L-glutamic acid | |
| JP7851853B2 (ja) | 分子内転位を受けるコンジュゲート |